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Abstract
OBJECTIVE: To evaluates the antioxidant and hepa-
toprotective potentials of Dicoma anomala Sond.
(Asteraceae) on body weight, feed and water in-
take, biochemical parameters and organ histology.
METHODS: Various concentrations (1.56-25 µg/mL)
were used in the in vitro assays 1,1-diphenyl-2-pic-
ryl hydrazyl (DPPH, superoxide anion, hydroxyl radi-
cals, etc.). The effects of treatment with 125, 250
and 250 mg/mL Dicoma anomala aqueous roots ex-
tract (DARE) was investigated in vivo in the CCl4-in-
duced hepatotoxic rats during the 15 days study.
RESULTS: Water extract exhibited the best activity
(IC50: 15.20 ± 0.03, 11.70 ± 0.10, and 0.84 ± 0.05 µg/
mL) in vitro in DPPH, hydroxyl and superoxide an-
ion radicals, respectively, when compared with
standards. Pre-treatment and treatment with differ-
ent concentrations of DARE significantly (P < 0.05)
attenuated the elevated serum activities of aspar-
tate transaminase, alanine transaminase levels
while increasing the activities of superoxide dis-
mutase, catalase and glutathione peroxidase. The
histopathological evaluations revealed extensive
liver damage characterized by severe vacuolar and
cytoplasmic degeneration, hepatic necrosis, and
cellular infilteration in pre-treated groups while in
the treated groups; such liver damages were not
observed most especially at 500 mg/kg dose.
CONCLUSION: The results proved the hepatopro-
tective potential of DARE against CCl4-induced oxi-
dative stress. Moreover, histopathological examina-
tions revealed better therapeutic advantage of
DARE than prophylactic use.
Key words: Dicoma anomala Sond. (Asteraceae);
Antioxidant enzymes; Carbon tetrachloride; Hepa-
toprotection; Lipid peroxidation
INTRODUCTION
Free radicals are implicated in the pathogenesis of sever-
al degenerative diseases including liver damage. Their
deleterious influence causes oxidative stress which is a
reflection of disequilibrium between them and the
body's antioxidant defence system. This result in signif-
icant damage to important cellular macromolecules
(proteins, lipids and DNA) and ultimately cell necro-
sis.1When this happens, swiftly intervention with exog-
enous antioxidants2 (which could be easily and readily
achieved through consumption of vegetables and
fruits) augments the cellular defence system thereby
preventing cell death. Foods of plant origin usually con-
tain natural antioxidants that can scavenge free radi-
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cals2 and there is a great deal of interest in edible plants
with excellent phytonutrients primarily due to their
health benefits.
Dicoma anomala Sond. (Asteraceae) commonly called
fever or stomach bush (Eng.) or hloenya (South Sotho)
is a prostrate. Decumbent or erect perennial herb with
underground tuber. D. anomala is widely distributed
in sub-Sahara Africa including most Provinces within
South Africa.3 The plant is ethno-botanically indicated
in the treatment of cold and coughs, fever, ulcers and
dermatosis. Its pharmacological potentials as antiplas-
modial, antibacterial, anthelmintic, antiviral and an-
ti-inflammatory have also been documented.4 Till date,
there is paucity of information in scientific literatures
on the hepatoprotective potentials of D. anomala.
Therefore, the present study reports on this with focus
on its curative and prophylactic models.
MATERIALS ANDMETHODS
ChemicalsCarbon tetrachloride, 2, 2- azino-bis (3-ethylbenzothia-
zoline-6-sulfonic acid) and assay kits were purchased
from Sigma-Aldrich (Johannesburg, South Africa). All
other chemicals and reagents used were of analytical
grade.
Plant collection and extractionFresh root stocks of Dicoma anomala were procured in
April 2014 from Setsing market, Phuthaditjhaba, Free
State Province, South Africa. The sample was con-
firmed by Dr. AOT Ashafa of Plant Sciences depart-
ment, University of the Free State, South Africa. A
voucher specimen was prepared and deposited at the
herbarium. The rootstocks were cut into smaller pieces;
oven dried (40℃), and pulverized using a Waring com-
mercial blender (Waring Instrument, Torrington, CT,
USA) into fine powder. Approximately 10 g each from
the powdered materials was exhaustively extracted with
40 mL each of water, ethanol, aqueous ethanol and
methanol. They were filtered and organic extracts were
concentrated using a rotary evaporator (Cole-Palmer,
model SB-1100 Shanghai, China) to obtain dry brown
crude extracts. The water extract was dried on a water
bath (Memmert W600, Schwabash, Germany) at
45 ℃. The crude extracts were reconstituted in respec-
tive solvents to prepare various concentrations used for
the in vitro antioxidant assays.
Similarly, 200 g of the powdered material was extracted
with 2 L of water, filtered and concentrated to dryness
on water bath at 40 ℃. The extraction yielded 48.87 g
of brown gum (24.435% w/w of dry plant material).
The crude extract was reconstituted in water to give
various concentrations used for the in vivo assays.
In vitro antioxidant assays
The 1,1-diphenyl-2-picryl hydrazyl DPPH radical scav-
enging activity of the extracts determined using Braca
et al.5 method, nitric oxide,6 reducing power,7 metal
chelating,8 2, 2-azino-bis (3-ethylbenzothiazoline-6-
sulfonic acid ABTS,9 superoxide anion,10 hydroxyl radi-
cal,11 total antioxidant capacity,12 total phenolic con-
tent13 and total flavonoids according to Chang et al.14
In vivo hepatoprotective study
Experimental animals: male and female Wistar rats
(Rattus norvegicus, 10 weeks old) weighing 145.00 ±
10.00 g were used in this study. They were procured
from the animal house of the University of the Free
State, Bloemfontein. They were acclimatized for one
week, fed with standard rat feed (Epol mice cubes,
Westville, South Africa) and water ad libitum. Ethical
clearance (number NR 02/13) to undertake the study
was obtained from the Interfaculty Animal Ethical
Committee of the University of the Free State prior to
the commencement of the study.
Experimental design: the hepatoprotective study was
conducted according to Chandan et al.15 method with
slight modifications. A total of 66 rats were randomly
divided into eleven groups of six animals each (n = 6).
Group A animals were orally administered 1 mL nor-
mal saline for 15 days. Groups B and C rats received
1 mL/kg CCl4 (in olive oil; ratio 1∶1 v/v) i.p on days 1
and 15 and represented curative and prophylactic hepa-
totoxic rats, respectively. Groups D-G rats were cura-
tive hepatotoxic rats treated orally with silymarin
(100 mg/kg body weight BW), 125, 250 and 500 mg/kg
BW Dicoma anomala aqueous roots extract DARE re-
spectively. Groups H-K represented prophylactic hepa-
totoxic rats given respective similar treatments as in the
curative study and CCl4 i.p on the 15th day of the ex-
periment.
Serum preparation and organ isolation: at the end of
experimental period, all the rats were anaesthetized
with halothane and blood was collected by cardiac
puncture. An aliquot (2 mL) of the blood collected in-
to ethylenediamine tetraacetic acid EDTA bottle was
used for the analysis of haematological parameters,
while another 5 mL of the blood collected in non-hepa-
rinized bottle was centrifuged at 1285 × g for 10 min
and the resulting serum was aspirated and used for oth-
er serum bioassays.
The animals were quickly dissected and the liver, kid-
ney, heart and lungs were excised, freed of fat and
weighed for evaluation of organ -body weight ratios.
The liver was further divided into two portions and a
portion immediately fixed in 10% formalin for histo-
pathological examination, while the other was homoge-
nized in ice cold 0.1 mol/L Tris-HCl buffer (pH 7.2),
at 10 000 rpm for 15 min and the supernatant ob-
tained was kept at －80 ℃ freezer prior further bioas-
says.
Determination of haematological and biochemical pa-
rameters: the automated haematologic analyzer (Sys-
mex, KX-21, Chuo-ku, Kobe, Japan) was used to anal-
yse total protein, bilirubin levels and haematological
parameters. The serum levels of total cholesterol, high
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density lipoprotein cholesterol (HDL-c), low density li-
poprotein cholesterol (LDL-c) and triglycerides were
determined using standard procedures.16-19
Antioxidant enzymes assays
Catalase activity in tissues determined based on adapt-
ed method of Aebi,20 glutathione peroxidase activity21
and superoxide dismutase activity.22 Lipid peroxidation
was assayed by the formation of thiobarbituric acid re-
active substances.23
Histopathological studies
The fixed liver tissues was dehydrated in graded
(50%-100% ) alcohol, embedded in paraffin, cut into
4-5 µm thick sections and stained with hematoxylin-eo-
sin. The sections were evaluated for the pathological/re-
juvenative changes in the hepatocytes.
Statistical analysis
Data analysis were done by one way analysis of vari-
ance, followed by Bonferroni's multiple comparison
test and results were expressed as mean of three/six rep-
licates (in vitro and in vivo assays respectively) ± SEM
using Graph pad (Graph Pad software, San Diego, CA,
USA). Statistical significancewas considered atP<0.05.
RESULTS
In vitro assays
The scavenging activities of the extracts on the evaluat-
ed in vitro antioxidant assays are presented in Table 1.
Judging by the half maximal inhibitory concentration
(IC50) values, water extract was the most potent in scav-
enging DPPH, hydroxyl, and superoxide anion radicals
when compared with other extracts and standards. For
the nitric oxide and ABTS inhibitions, best effects were
elicited by ethanolic and hydroethanolic extracts respec-
tively. With the exception of hydroethanolic extract,
others revealed good activity in the metal chelating ac-
tivity. A steady reducing power effect was also exhibit-
ed by the hydroethanolic extract of D. anomala com-
pared with vitamin C (Figure 1). The hydroethanolic ex-
tract had the highest amount of total antioxidant
and total phenolic contents, while the highest
amount of flavonoids was found in the ethanolic ex-
tract (Table 2).
Feed and water intake
As observed in this study (result not shown), there was
no significant (P > 0.05) difference in the feed and wa-
ter intake on the animals of all the treated groups com-
pared to control.
Body weight
The effect of DARE on body/organ weight of rats is
shown in Table 3. In both study, CCl4 significantly
(P < 0.05) reduced the body weight of the rats when
compared with normal control, pre-treatments and
treatment with DARE enhances the body weight gain
of the animals. The observed effect was also reflected in
the average weight of the various excised organs.
Haematological parameters
Table 4 showed the effect of DARE on haematological
parameters. In the both study, CCl4 raised the level of
red blood cells (RBC) and haemoglobin, while it signif-
icantly (P < 0.05) reduced the concentration of neutro-
phils, lymphocytes, monocytes and WBC (though in-
different in prophylactic study) compared to normal
control. These alterations were significantly (P < 0.05)
improved towards normal following treatment with
DARE and silymarin. Other haematological indices
were not affected in the two studies.
Lipid profile
The effect of DARE on lipid profile is shown in Table
5. In the two studies, the significantly (P < 0.05) in-
creased levels of triglycerides, total cholesterol and
LDL-c coupled with lowered concentration of HDL-c
in the hepatotoxic rats were significantly (P < 0.05)
moderated towards normal following treatment with
DARE and silymarin.
Table 1 In vitro antioxidant capability of different extracts of Dicoma anomala root (n = 3, xˉ ± s)
Assay
DPPH
Metal chelating
Hydroxyl radical
Nitric oxide
Superoxide anion
ABTS
Extracts (IC50 µg/mL)
Water
15.200±0.030ab
8.500±0.290ab
11.700±0.100ab
47.000±1.800a
0.840±0.050a
1.200±0.100b
Ethanol
336.900±41.060ab
6.100±0.100ab
160.900±10.850ab
0.770±0.070ab
21.000±0.720ab
20.000±0.280b
Hydro-ethanol
32.490±0.610b
278.000±0.710ab
21.710±0.150ab
39.000±0.130a
2.900±0.000a
0.600±0.020b
Methanol
109.300±0.310a
3.500±0.220ab
44.830±0.580ab
58.000±1.700ab
0.890±0.140ab
12.000±0.200a
Gallic acidα
33.930±0.400
69.370±9.170
93.770±0.840
30.020±1.560
131.200±4.510
2.500±0.050
Vitamin Cβ
71.490±0.760
116.100±3.850
280.800±23.910
38.000±0.030
3.000±2.560
15.560±0.340
Notes: scavenging abilities of different extracts of Dicoma anomala against 1, 1-diphenyl- 2-picrylhydrazyl radical, 2, 2- azino-bis (3-ethyl-
benzothiazoline)-6-sulfonic acid, hydroxyl radical, nitric oxide, iron chelation and superoxide anion radical. Aliquots of varying concentra-
tions (1.56 - 25 µg/mL) of the extracts (water, ethanol, hydro-ethanol, and methanol) and standards (gallic acids, vitamin C) were tested to
assess the scavenging abilities of different extracts of D. anomala. DPPH: 1, 1-Diphenyl-2-picryl hydrazyl; ABTS: 2, 2- Azino-bis (3-ethyl-
benzothiazoline)-6-sulfonic acid. Significantly different compared to gallic acid aP < 0.05; compared to βvitamin C, bP < 0.05.
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Effect on liver function indices and antioxidant
marker parameters
Table 6 and 7 present the effect of DARE on liver func-
tion parameters and the antioxidant status of the ani-
mals, respectively. There was no significant difference
(P > 0.05) in total bilirubin and total protein levels in
both studies. Similarly results from both studies
showed that CCl4 administration significantly (P <
0.05) increase the tissue level of TBARS as well as se-
rum activities of alanine transaminase (ALT) and aspar-
tate amino transferase (AST), while the tissue activities
of catalase (CAT), superoxide dismutase (SOD) and
glutathione peroxidase (GPx) were significantly re-
duced when compared with the normal control. Treat-
ment with different doses of DARE reversed these
trends and the effect noticed competed well with sily-
marin.
Effect on organ histology
The effect of DARE on the microscopic examination
of the liver is shown in Figure 2. As observed, 500 mg/
kg DARE was able to restore the effect of CCl4 in-
duced hepatotoxicity in the curative study.
DISCUSSION
Plant phenolics are major group of compounds with
high antioxidant activity, which is attributed to their
ability to absorb, neutralize and quench the activity of
free radicals.24 The highest activity of water extract ob-
served in most of the in vitro antioxidant tested assays
could possibly suggest the polar nature of bioactive
compounds in D. anomala, thus, suggesting the choice
of aqueous extract for the hepatoprotective study. The
high phenolic content observed could be attributed to
the presence of hydroxyl group attached to the aromat-
ic ring structures which confers strong activity to the
compounds thus quench the effect of free radicals.25
The haematopoietic profile is an important index for
determining the physiological and pathological status
of humans and animals.26 The significant increase in
red blood cells (RBC) and haemoglobin of the hepato-
toxic rats when compared with normal control and
their subsequent reduction in the treatment groups was
an indication of the extracts' capability to restore
RBC's morphology and to prevent alteration in its os-
motic fragility. However, increase in white blood cells
(WBC) and its related indices in the curative treat-
Table 2 Yield, total antioxidant activity and quantitative phytochemical contents of D. anomala root extracts (n = 3, xˉ ± s)
Extracts
Water
Ethanol
Hydro-ethanol
Methanol
Yield (%)
23.04
10.97
36.63
28.50
Total antioxidant
(mg GAE/100 g extract)
137.20±1.95a
153.80±3.66b
213.40±0.99c
166.90±3.61d
Total phenols
(mg GAE/100 g extract)
254.00±0.38a
145.90±0.19b
426.80±0.73c
316.00±0.51d
Total flavonoids
(mg QUE/100 g extract)
46.33±0.14a
61.24±0.23b
50.94±0.14c
56.89±0.14c
Notes: values with different superscripts (a, b, c, d) along the same column for each parameter are significantly different (P < 0.05) com-
pared to each other. GAE: Gallic acid extract; QUE: quercetin extract. Varying concentrations (1.56-25 µg/mL) of the extracts (water, etha-
nol, hydro-ethanol and methanol) and standards (Gallic acids, Vitamin C) were used to assess the scavenging abilities of different extracts
of D. anomala.
Figure 1 Reducing capabilities of different extracts of Dicoma anomala roots
Values are expressed as means ± standard error of mean (SEM) of triplicate determinations. Bars (or groups) bearing superscript
(a, b) for each concentration are statistically significant (P < 0.05) compared to the control (vitamin C). Aliquots of varying concen-
trations (1.56 - 25 µg/mL) of the extracts (water, ethanol, hydro-ethanol, methanol) and standard (vitamin C) were used to as-
sessed the reducing capabilities of D. anomala.
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ments reflected non-toxic nature
and leucocytic tendency of the ex-
tract.
Derangements in metabolism and
oxidation of lipid molecules have
been implicated in the etiopatho-
genesis and progression of human
diseases.27 Elevated levels of lipids
in serum, particularly cholesterol
linked with generation of reactive
oxygen species (ROS) are vital in
the development of atherosclerosis
and coronary artery disease. More-
over, increased risk of atherosclero-
sis arising from elevated levels of
all lipids except HDL-c has been
reported.28 In the present study,
DARE suggests hypolipidemic ac-
tivity as the extracts reduces plas-
ma cholesterol, LDL-c and triglyc-
erides following the curative and
prophylactic treatments, this
might suggest the beneficial effect
(s) of the plant in reducing plasma
lipid profiles.
Liver, the largest organ in the body
is concerned with the metabolism
of foreign compounds, which
makes it susceptible to many dis-
eases such as hepatitis, cirrhosis,
liver cancer caused due to expo-
sure to various environmental pol-
lutants, drugs such as carbon tetra-
chloride, paracetamol, thioacet-
amide etc., thereby resulting in the
formation ROS ultimately damag-
ing the liver.29
CCl4 is a hepatotoxin whose ac-
tion has been attributed to its me-
tabolism by cytochrome P450 to tri-
chloromethyl radical (CCl3-).
CCl3- is not only toxic but act as
free radical initiators which in-
crease the hepatic lipid peroxida-
tion products and thus facilitates
liver damage. An obvious sign of
liver damage is leakages of cellular
enzymes via the hepatocytes' mem-
brane into the bloodstream30 there-
by increasing the level of these en-
zymes in the serum. Estimation of
these enzymes in the serum is an
important marker to the extent
and types of damage on the liver.31
In this study, the significantly in-
creased serum activities of CCl4
treated rats was an obvious indica-
tion of liver damage. The normal-Par
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ization in the activities of
these enzymes in both treat-
ments with DARE is indica-
tive of its potential in main-
taining normal functioning
status of the liver. This is in
agreement with the finding
of Sreelatha et al 29 who gave
similar observation follow-
ing treatment of hepatotox-
ic rats with Coriandrum sa-
tivum extract. The total pro-
tein and bilirubin level in
the serum is an indication
of the state of the liver and
type of damage.32 Liver dam-
age arising from low level of
protein in the blood (hypo-
proteinemia) is a conse-
quence of decrease in the
synthesis of protein.33 The
insignificant decrease in se-
rum total protein observed
in our study for the hepato-
totoxic rats could be attrib-
uted to the damaged hepato-
cellular functions and the
indifference in bilirubin lev-
els compared to normal
might suggest the intact
state of the biliary tract.
Free radicals generated by
CCl4 damage increase hepat-
ic lipid peroxidation thr-
ough the generation of lipid
peroxide products like malo-
ndialdehyde (MDA) and
thiobarbituric acid reactive
species (TBARS).34 Our
study showed that adminis-
tration of a single dose of
CCl4 caused liver damage
and oxidative stress as re-
vealed by the increase in lip-
id peroxidation. This obser-
vation might have resulted
from the inability of the an-
tioxidant defense mecha-
nisms of the rats to prevent
excessive free radical forma-
tion. However, the signifi-
cant attenuation in the level
of TBARS in the two stud-
ies when compared with the
hepatotoxic animals is sug-
gestive of antioxidative po-
tentials of DARE, thereby
preventing hepatic free radi-Tab
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cal formation by directly interfering with cytochrome
P450.35
SOD is one of the major cellular defense enzymes
that dismutate superoxide radical to produce H2O2
and oxygen. The observed reduction in the activity of
SOD following the CCl4 administration suggests oxi-
dative stress.36 DARE ameliorated this effect suggest-
ing its hepatoprotective attribute. GPx is the first line
defense against free radicals. It requires a cofactor for
maximum efficiency. The ability of the extract to
boost the reduced activity of GPx could possibly sug-
gest the presence of elements such as zinc in the ex-
tract responsible for the increased synthesis of the en-
zyme. Catalases are heme-containing proteins con-
cerned with cell protection from toxic effects of ROS.
The reduction in the activity of catalase following
CCl4 administration might be an indication of im-
paired antioxidant status in the hepatocytes of the rats
and ultimately membranal liver damage.37 The ability
of DARE to reverse and normalize this effect further
corroborates the antioxidant and hepatoprotective ef-
fects of the herb. Our submissions are consistent with
the findings of Coriandrum sativum L. (Apiaceae)29
and Strychnos henningsii Gilg. (Loganiaceae)38 where
similar observations were given.
The histopathological study revealed the complete res-
toration of the liver integrity by DARE following
CCl4 liver injury most especially at the highest concen-
tration of 500 mg/kg in the curative study. This cor-
roborates the results obtained from biochemical assays
and further buttresses the hepatoprotective potential
of the plant.
The overall effects displayed by DARE may be as-
cribed to its possession of excellent antioxidant princi-
ples as revealed in the present study with respect to to-
tal flavonoid and phenol contents. These compounds
have been studied to be hepatoprotective 25,32 and thus
supportive of the submissions in the present study.
The results from this study revealed that DARE elicit-
ed excellent hepatoprotective activity against CCl4 in-
duced liver damage and may be embraced as neutri-
ceutical in the management and treatment of liver re-
lated disorders. Further studies are suggested to iso-
late, purify and structurally elucidate the exact active
principles responsible for the observed effects in this
study.
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